Edward Littleton - Concepedia

Author

Edward Littleton

Also Known As

Don Sims, E Littleton, E T Littleton, E. Littleton, E.T. Littleton, Edward Littleton, Edward T Littleton, Edward T. Littleton, John Bamford, Littleton, E

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

University College London John Radcliffe Hospital University of Edinburgh University of Oxford National Hospital for Neurology and Neurosurgery

About

Edward Littleton is an author at University College London specializing in medicine, neurology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.7K
2	Public Health	2	2	1.4K
3	Allergy	1	1	12
4	Epidemiology	1	1	1.3K
5	Hepatology	1	1	12

Edward Littleton

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study Aravinthan Varatharaj, Naomi Thomas, Mark Ellul, The Lancet Psychiatry Virus EpidemiologyNeurovirologyUk-wide Surveillance StudyNeuropsychiatric ComplicationsGlobal Health Crisis	2020	1.3K
Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis Patrick Waters, Sven Jarius, Edward Littleton, Archives of Neurology	2008	291
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial Martin Dennis, Gillian Mead, John Forbes, The Lancet	2018	276
Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica Friedemann Paul, Sven Jarius, Orhan Aktaş, PLoS Medicine	2007	208
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock, The Lancet	2019	188
NMO-IgG in the diagnosis of neuromyelitis optica Sven Jarius, D. Franciotta, Roberto Bergamaschi, Neurology Ocular DiseaseNeurological DisorderImmunologyClinical NeurologyPathology	2007	182
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy, The Lancet ThrombosisSuperiority TrialIschemic StrokeCardiovascular DiseaseMedicine	2024	101
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial Rustam Al‐Shahi Salman, David Minks, Dipayan Mitra, The Lancet Neurology	2019	88
AChR phosphorylation and indirect inhibition of AChR function in seronegative MG C.P. Plested, T. M. Simon Tang, Ian Spreadbury, Neurology	2002	66
Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage Rustam Al‐Shahi Salman, Martin Dennis, Peter Sandercock, JAMA Neurology	2021	47

Page 1